Chalfont St. Giles, UK and Lyon, France – 2 November, 2016 – GE Healthcare’s Life Sciences business and Valneva SE, a fully integrated vaccine biotech company, are sharing the results of a successful collaboration to optimize virus productivity in Valneva’s EB66® cell-line, a proprietary technology for the production of a wide variety of vaccines, including... Read more
CHALFONT ST. GILES, UK – 1 November 2016 – GE Healthcare’s Life Sciences business, a global provider of expertise, tools and technologies to the biotech industry, announced today a USD 7 million expansion project at its single-use technology manufacturing facility in Westborough, MA, US. The expanded site will manufacture a range of single-use products, including... Read more
Mumbai, October 17, 2016: Tata Trusts and GE Healthcare today announced a partnership to train 10,000 youth in various technical areas of healthcare over a three-year period. The partnership will focus on bridging the skills gap in healthcare technical or operating staff. The announcement was made in the presence of Mr. Ratan Tata, Chairman of... Read more
CHALFONT ST. GILES, UK – 30 September 2016 –At the International Society for Cellular Therapy’s Regional Meeting in Memphis, TN, GE Healthcare’s recently acquired Biosafe Group introduces Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing and final formulation during cell processing. Combined with GE... Read more
Chalfont St. Giles, UK and Songdo, Korea – 29 September 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, announced today the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new USD 7.4 million Center will... Read more
CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 – R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more
CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 – R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more
CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork. GE BioPark Cork, subject to contract and planning approvals,... Read more
Rome – 27 August 2016 – In the lead up to the European Society of Cardiology Congress in Rome Italy, GE Healthcare today announced the global commercial launch[1] of its new generation of high-end portable compact cardiovascular ultrasound, the Vivid™ iq. A smaller sized compact weighing just 4.5 kg, the Vivid™ iq matches exceptional image... Read more
Chalfont St Giles, UK – 23 August 2016 – In a further step to build its portfolio for the rapidly-growing cell therapy industry, GE Healthcare today announced an agreement with STEMCELL Technologies Inc. of Vancouver, Canada to provide T-Cell reagents for commercial-scale cell therapy production. Under the agreement, GE Healthcare will commercialize cGMP-grade versions of... Read more